COMBINED APPLICATION OF OKOMISTIN® И OFTALMOFERON® EYE DROPS IN TREATMENT OF ADENOVIRAL CONJUNCTIVITIS
Purpose. To evaluate the clinical efficacy of a combined application of Okomistin and Oftalmoferon compared to an Oftalmoferon monotherapy in the treatment of viral conjunctivitis. Material and methods. We observed 38 patients with various forms of clinical progression of viral eye diseases: adenovi...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Publishing house "Ophthalmology"
2015-12-01
|
| Series: | Офтальмохирургия |
| Subjects: | |
| Online Access: | https://www.ophthalmosurgery.ru/jour/article/view/111 |
| Summary: | Purpose. To evaluate the clinical efficacy of a combined application of Okomistin and Oftalmoferon compared to an Oftalmoferon monotherapy in the treatment of viral conjunctivitis. Material and methods. We observed 38 patients with various forms of clinical progression of viral eye diseases: adenoviral conjunctivitis (AVC) – 26 patients, shipyard disease – 12 patients. The patients’ age ranged from 19 to 68 years. Okomistin and Oftalmoferon eye drops were used as basic drugs according to the following scheme: Okomistin followed by Oftalmoferon in 10-15 minutes. Instillations repeated 8-10 times a day. Since the 5th day of treatment the instillations were reduced up to 6 times a day, and then to 4 times daily. Results. During this therapy for the AVC periods of conjunctiva normalization with disappearance of inflammatory effects decreased up to 6.2 days. In case of shipyard disease in administration of combined therapy with the Okomistin + Oftalmoferon medicine the treatment period lasted 12.3 days. The positive therapeutic effect was observed in 96% of cases.Conclusions. The combined use of Okomistin and Oftalmoferon compared to the Oftalmoferon monotherapy in the treatment of viral conjunctivitis has a more pronounced therapeutic effect. |
|---|---|
| ISSN: | 0235-4160 2312-4970 |